Therapeutic Drug Monitoring of Gabapentine.

被引:4
|
作者
Tribut, Olivier [1 ]
Bentue-Ferrer, Daniele [1 ]
Verdier, Marie-Clemence [1 ]
机构
[1] CHU Pontchaillou, Lab Pharmacol Biol, F-35033 Rennes, France
来源
THERAPIE | 2010年 / 65卷 / 01期
关键词
gabapentin; therapeutic drug monitoring; PERFORMANCE LIQUID-CHROMATOGRAPHY; PARTIAL SEIZURES; ANTIEPILEPTIC DRUGS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; SERUM; EPILEPSY; PLASMA; PHARMACOKINETICS; BIOAVAILABILITY;
D O I
10.2515/therapie/2009069
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Therapeutic Drug Monitoring of Gabapentine. Gabapentin is a structural analogue of GABA used in the treatment of the partial epilepsies of adult and child of more than 12 years, in monotherapy or in association with other anticonvulsant drugs. In association, gabapentin presents the advantage of not interfering with the other anticonvulsant drugs. The interindividual pharmacokinetic variability and the saturable absorption are, with the adaptation in case of renal insufficiency, the only arguments in favor of TDM. During clinical studies, the plasma concentrations of gabapentin were generally included between 2 and 20 mg/L. For this molecule, the level of proof of the interest of therapeutic drug monitoring was estimated in: possibly useful.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [31] Review on the relevance of therapeutic drug monitoring of levetiracetam
    Sourbron, Jo
    Chan, HoiYau
    Wammes-van der Heijden, Elisabeth A.
    Klarenbeek, Pim
    Wijnen, B. F. M.
    de Haan, Gerrit-Jan
    van der Kuy, Hugo
    Evers, Silvia
    Majoie, Marian
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 62 : 131 - 135
  • [32] Usefulness of saliva for perampanel therapeutic drug monitoring
    Kim, Do-Yong
    Moon, Jangsup
    Shin, Yong-Won
    Lee, Soon-Tae
    Jung, Keun-Hwa
    Park, Kyung-Il
    Jung, Ki-Young
    Kim, Manho
    Lee, SeungHwan
    Yu, Kyung-Sang
    Jang, In-Jin
    Song, KaHeon
    Chu, Kon
    Lee, Sangkun
    EPILEPSIA, 2020, 61 (06) : 1120 - 1128
  • [33] Lamotrigine Drug Interactions in Combination Therapy and the Influence of Therapeutic Drug Monitoring on Clinical Outcomes of Adult Patients
    Grundmann, Milan
    Koristkova, Blanka
    Brozmanova, Hana
    Kacirova, Ivana
    THERAPEUTIC DRUG MONITORING, 2017, 39 (05) : 543 - 549
  • [34] Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients
    Koristkova, Blanka
    Grundmann, Milan
    Brozmanova, Hana
    Kacirova, Ivana
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 (01) : 26 - 33
  • [35] Therapeutic drug monitoring in epileptology and psychiatry ["Therapeutic drug monitoring" in epileptologie und psychiatrie]
    Brandt C.
    Baumann P.
    Eckermann G.
    Hiemke C.
    May T.W.
    Rambeck B.
    Pohlmann-Eden B.
    Der Nervenarzt, 2008, 79 (2) : 167 - 174
  • [36] LC Method for the Determination of Meropenem in Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring
    Matsuda, Tomoko
    Ikawa, Kazuro
    Ikeda, Kayo
    Morikawa, Norifumi
    Tsumura, Ryu
    Shibukawa, Masaaki
    Iida, Koji
    Kurisu, Kaoru
    CHROMATOGRAPHIA, 2009, 69 (9-10) : 1031 - 1034
  • [37] Therapeutic drug monitoring of free perampanel concentrations in practice: A practical analytical technique based on centrifugal ultrafiltration sample separation
    Ma, Ying-Hua
    Dong, Lei
    Wu, Jia-Xuan
    Hu, Shi-Yuan
    Meng, Xiang-Fei
    Zhao, Yi-Le
    Liu, Kang
    Yan, Dan-Ni
    Sun, Su-Zhen
    HELIYON, 2024, 10 (15)
  • [38] Therapeutic drug monitoring of olanzapine
    Djerada, Zoubir
    Brousse, Georges
    Niel, Philippe
    Llorca, Pierre-Michel
    Eschalier, Alain
    Bentue-Ferrer, Daniele
    Libert, Frederic
    THERAPIE, 2023, 78 (05): : S75 - S80
  • [39] Therapeutic Drug Monitoring of Valproate
    Bentue-Ferrer, Daniele
    Tribut, Olivier
    Verdier, Marie-Clemence
    THERAPIE, 2010, 65 (03): : 233 - 240
  • [40] Therapeutic Drug Monitoring of Lacosamide
    Bentue-Ferrer, Daniele
    Tribut, Olivier
    Verdier, Marie-Clemence
    THERAPIE, 2012, 67 (02): : 151 - 155